|
Federal
Register Notices > Notices of
Registration - 2007
>
Boehringer Ingelheim Chemicals, Inc
FR Doc E7-23480 [Federal Register: December 4, 2007 (Volume 72, Number 232)]
[Notices] [Page 68193] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04de07-98]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated August 16, 2007, and published in the Federal Register on
August 27, 2007 (72 FR 49018), Boehringer Ingelheim Chemicals, Inc., 2820 N.
Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the
Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of
the basic classes of controlled substances listed in schedules I and II:
|
Drug
|
Schedule
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methylphenidate (1724)
|
II
|
|
Methadone (9250)
|
II
|
|
Methadone Intermediate (9254)
|
II
|
|
Dextropropoxyphene, bulk (non-dosage forms)(9273)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture the listed controlled substances in bulk for
sale to its customers for formulation into finished pharmaceuticals.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Boehringer Ingelheim
Chemicals, Inc. to manufacture the listed basic classes of controlled substances
is consistent with the public interest at this time. DEA has investigated
Boehringer Ingelheim Chemicals, Inc. to ensure that the company's registration
is consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems, verification
of the company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in
accordance with 21 CFR
1301.33, the above named company is granted registration
as a bulk manufacturer of the basic classes of controlled substances listed.
Dated: November 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E7-23480 Filed 12-3-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
